Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 240-815-0 | CAS number: 16752-77-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Methomyl
- EC Number:
- 240-815-0
- EC Name:
- Methomyl
- Cas Number:
- 16752-77-5
- Molecular formula:
- C5H10N2O2S
- IUPAC Name:
- (E)-[1-(methylsulfanyl)ethylidene]amino N-methylcarbamate
- Test material form:
- solid: crystalline
Constituent 1
- Specific details on test material used for the study:
- Methomyl technical
Lot No.: DPX-X1179-512
Purity: 98.8%
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/JHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Sprague Dawley, Fredrick, Maryland, U.S.A.
- Females nulliparous and non-pregnant: Yes
- Age at study initiation: Approximately 9 weeks old
- Weight at study initiation: 19.3-24.3 g
- Housing: Animals were housed 1 group per plastic shoebox cage with appropriate bedding
- Diet: LLC Certified Rodent LabDiet# 5002, ad libitum
- Water: Tap water, ad libitum
- Acclimation period: Quarantined for 6 days
ENVIRONMENTAL CONDITIONS
- Temperature: 18-26°C
- Humidity: 30-70%
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (LLNA)
- Vehicle:
- dimethylformamide
- Concentration:
- 0, 5, 25, 50 and 100%
Positive control: 0 and 25% - No. of animals per dose:
- 5
- Details on study design:
- PRE-SCREEN TESTS:
- weighed 3 times during quarantine and 4 times prior to initiation of dosing
- observed with respect to weight gain and any gross signs of disease or injury
MAIN STUDY : 25 µL of the test substance were administered topically to the dorsum of each mouse ear for 3 consecutive days (test days 0-2). One group of mice was similarly dosed with the positive control and one group of mice was similarly dosed with the positive control vehicle. Test days 3-4 were days of rest followed by intravenous injection of 20 µCi of 3H-Thymidine per mouse on test day 5. Approximately 5 hours after the injection, animals were sacrificed by carbon dioxide asphyxiation, draining auricular lymph nodes were removed, and single cell suspensions were prepared. The single cell suspensions were incubated at 2-8°C overnight. On test day 6, the single cell suspensions were counted on a beta counter. The counts per minute (cpm) data were convened to disintegrations per minute (dpm).
A stimulation index (SI) was derived for each experimental group by dividing the mean dpm of each experimental group by the mean dpm of the vehicle control group.
ANIMAL ASSIGNMENT AND TREATMENT
- Mice, selected based on adequate body weight gain and freedom from any ear abnormalities (e.g. torn, scratched) or clinical signs of disease or injury, distributed into study groups. Prior to study start, each mouse was assigned to a group using a randomly generated, computer-based algorithm such that individual pretest body weights did not vary more than 20% of the group mean.
- Criteria used to consider a positive response: Statistically significant increases in cell proliferation in the test concentration groups compared to the vehicle control group and/or SI's of greater than or equal to 3.0 indicated a positive response. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- - Bodyweight, bodyweight gain and Lymph node dpm data: If the Shapiro-Wilk test was not significant but Levene's test was significant, a robust version of Dunnett's test was used. If the Shapiro-Wilk test was significant, Kruskal-Wallis test was followed by Dunn's test.
Positive control and positive control vehicle data were not included in the statistical analysis of the test substance groups.
- Incidence of clinical observations: If the incidence was not significant, but a significant lack of fit occurred, then Fisher's Exact test with a Bonferroni correction was used.
Results and discussion
- Positive control results:
- A 25% concentration of the positive control, HCA, produced a dermal sensitization response in mice.
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- 0.54
- Test group / Remarks:
- 5%
- Key result
- Parameter:
- SI
- Value:
- 0.35
- Test group / Remarks:
- 25%
- Key result
- Parameter:
- SI
- Value:
- 0.23
- Test group / Remarks:
- 50%
- Parameter:
- SI
- Value:
- 6.9
- Test group / Remarks:
- 25% HCA (positive control)
- Cellular proliferation data / Observations:
- CELLULAR PROLIFERATION DATA
: No statistically significant increases in cell proliferation measurements compared to the vehicle control group were observed at any test concentration.
DETAILS ON STIMULATION INDEX CALCULATION & EC3 CALCULATION : Stimulation indexes of less than 3.0 were observed at all test concentrations of the test substance. Therefore, the EC3 value (the estimated concentration required to induce a threshold positive response, i.e., stimulation index = 3) for the test substance under the conditions of this study was not calculable.
CLINICAL OBSERVATIONS: No clinical signs of toxicity were observed in the study.
BODY WEIGHTS: A statistically significant decrease in mean body weight compared to the vehicle control group was observed in the 25% test concentration at test day 5. No statistically significant differences in mean body weights and body weight gains compared to the vehicle control group were observed at any other test concentration.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the conditions of this study, the test substance did not produce a dermal sensitization response in mice.
- Executive summary:
The objective of this study was to evaluate the potential of the test substance to produce a dermal sensitization response in mice using the local lymph node assay (LLNA) following OECD guideline 429 and U.S. EPA OPPTS 870.2600. Five groups of 5 female mice were dosed for 3 consecutive days with 0 (vehicle control), 5, 25, 50, or 100% test substance on both ears. N,N-dimethyIformamide was used as the diluting vehicle. One group of 5 female mice was dosed for 3 consecutive days with 25% hexylcinnamaldehyde (HCA) in 4:1 acetone:olive oil (AOO) as a positive control and one group of 5 female mice was dosed for 3 consecutive days with AOO as a positive control vehicle. On test day 5 of the assay, mice received 3H-Thymidine by tail vein injection and were sacrificed approximately 5 hours later. The cell proliferation in the draining auricular lymph nodes of the ears from the test substance groups was then evaluated and compared to the vehicle control group.
A statistically significant decrease in mean body weight compared to the vehicle control group was observed in the 25% test concentration at test day 5. No statistically significant differences in mean body weights and body weight gains compared to the vehicle control group were observed at any other test concentration. Six mice (606 and 607 in the 25% test substance group, and 1006, 1008, 1009, and 1010 in the 100% test substance group) were found dead on test day 1. Five of these mice (606, 607, 1006, 1009, and 1010) had no abnormality detected at necropsy. The remaining mouse (1008) had red lung discoloration at necropsy. One mouse (1007 in the 100% test substance group) was removed from study on test day 2 due to discontinuation of dosing that group. No clinical signs of toxicity were observed in the study. Given that the oral LD50 in rats is 32 mg/kg and that the mice in the 100% dose group received a dermal application of approximately 2500 mg/kg, which was not occluded, the observed deaths may be attributed to ingestion of the test material by the mice due to grooming.
No statistically significant increases in cell proliferation measurements compared to the vehicle control group were observed at any test concentration. Stimulation indexes of less than 3.0 were observed at all test concentrations of the test substance. Therefore, the EC3 value (the estimated concentration required to induce a threshold positive response, i.e., stimulation index - 3) for the test substance under the conditions of this study was not calculable. Based on these data, the test substance is not a dermal sensitizer.
A 25% concentration of the positive control, HCA, produced a dermal sensitization response in mice. Therefore, the LLNA test system was valid for this study with the test substance. Under the conditions of this study, the test substance did not produce a dermal sensitization response in mice.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.